Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

940
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
940
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

546
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
546
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

204
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
204
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

156
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
156
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

263
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
263

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association of maternal body mass index and cesarean delivery after preterm induction of labor.

American journal of obstetrics & gynecology MFM·2026
Same author

Selective Fetal Echocardiogram Referral Program for Pregnancies Affected by Pregestational Diabetes.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine·2026
Same author

The effect of metformin on perinatal outcomes in pregnant women with type 2 diabetes differs by baseline insulin requirements.

American journal of obstetrics and gynecology·2026
Same author

Association between Neonatal Hypoglycemia and 30-Day Breastfeeding Outcomes among Gravidas with Type 2 Diabetes.

American journal of perinatology·2026
Same author

Mild intrahepatic cholestasis of pregnancy-A call to redefine diagnostic criteria and consider a new management paradigm.

Pregnancy (Hoboken, N.J.)·2026
Same author

Contemporary trends in maternal outcomes during delivery hospitalizations among pregnancies complicated by von Willebrand disease-a cross-sectional analysis.

Research and practice in thrombosis and haemostasis·2025

Related Experiment Video

Updated: Jul 5, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

646

Routine screening for gestational diabetes: a review.

Minhazur R Sarker1, Gladys A Ramos

  • 1Division of Maternal-Fetal Medicine, University of California, San Diego, San Diego, California, USA.

Current Opinion in Obstetrics & Gynecology
|January 23, 2024
PubMed
Summary

The global rise in gestational diabetes mellitus (GDM) necessitates optimal screening. Current research suggests a 1-step screening approach increases GDM diagnoses but shows no significant benefit in population-level outcomes compared to the 2-step method.

More Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K

Related Experiment Videos

Last Updated: Jul 5, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

646
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K

Area of Science:

  • Obstetrics and Gynecology
  • Endocrinology
  • Public Health

Background:

  • Rising global rates of obesity correlate with increasing gestational diabetes mellitus (GDM) incidence.
  • Effective screening, diagnosis, and management of GDM are crucial due to its significant epidemiologic burden.
  • Current GDM screening guidelines vary globally, with ongoing debate regarding optimal methodologies.

Approach:

  • This review examines current international GDM screening guidelines.
  • It analyzes recent studies comparing 1-step and 2-step screening techniques.
  • The focus is on GDM incidence, perinatal outcomes, and future research directions.

Key Points:

  • The 1-step screening approach for GDM leads to higher diagnosis rates compared to the 2-step method.
  • However, the 1-step approach has not demonstrated significant population-level benefits in perinatal outcomes.
  • Existing comparative studies are underpowered to definitively assess outcomes for diagnosed GDM individuals.

Conclusions:

  • While the 1-step GDM screening increases case detection, its population-level impact on outcomes requires further investigation.
  • The optimal GDM screening strategy remains a subject of ongoing research and clinical debate.
  • Future research should focus on adequately powered studies to compare perinatal outcomes between different screening methods.